UpHealth, Inc. (UPHL)
OTCMKTS: UPHL · Delayed Price · USD
0.400
-0.002 (-0.57%)
Jul 19, 2024, 4:00 PM EDT - Market closed

Company Description

UpHealth, Inc. provides behavioral health solutions through the utilization of evidence-based treatments and services in the Americas.

The company offers mental health and substance use disorder treatment services directly to consumers.

It also provides detoxification, residential, partial hospitalization program, intensive outpatient program, outpatient services, and non-clinical recovery residence and supporting housing services.

UpHealth, Inc. is headquartered in Delray Beach, Florida.

UpHealth, Inc.
UpHealth logo
Country United States
Founded 2019
Industry Health Information Services
Sector Healthcare
Employees 374
CEO Martin S. A. Beck J.D., M.B.A.

Contact Details

Address:
14000 S. Military Trail, Suite 203
Delray Beach, Florida 33484
United States
Phone 888.424.3646
Website uphealthinc.com

Stock Details

Ticker Symbol UPHL
Exchange OTCMKTS
Fiscal Year January - December
Reporting Currency USD
CIK Code 0001770141
ISIN Number US91532B2007
Employer ID 83-3838045
SIC Code 8000

Key Executives

Name Position
Martin S. A. Beck J.D., M.B.A. Chief Executive Officer and Director
Dr. Mariya Pylypiv Ph.D. Co-Founder and Director
Dr. Chirinjeev Baboo Kathuria M.B.A., M.D. Co-Founder and Director
Jay W. Jennings Chief Financial Officer
Jordan DeMarie Vice President of Administration and Compliance
Jeremy Livianu Chief Legal and Compliance Officer
Lisa Fluxman President of Behavioral Health
Michael Clark Executive Vice President of Finance and Shared Services
Ragen Stone Executive Vice President Of Nursing
Salvatore Aiello Vice President of Revenue and Growth

Latest SEC Filings

Date Type Title
Jul 16, 2024 424B3 Prospectus
Jul 15, 2024 8-K Current Report
Jun 10, 2024 424B3 Prospectus
Jun 10, 2024 25-NSE Filing
Jun 6, 2024 8-K Current Report
Jun 6, 2024 10-Q Quarterly Report
May 20, 2024 8-K Current Report
May 15, 2024 NT 10-Q Notification of inability to timely file Form 10-Q or 10-QSB
May 10, 2024 8-K Current Report
Apr 16, 2024 424B3 Prospectus